title: The role of surgery in integrated therapies for non-small-cell lung cancer.
abstract: Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.
authors.affiliation: Division of Thoracic Surgery, University of Padua, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Sartori
authors.forename: L
authors.initials: L
authors.lastname: Bortolotti
authors.forename: M
authors.initials: M
authors.lastname: Michelon
authors.forename: F
authors.initials: F
authors.lastname: Colaut
authors.forename: M
authors.initials: M
authors.lastname: Loy
authors.forename: F
authors.initials: F
authors.lastname: Rea
authors.forename: A
authors.initials: A
authors.lastname: Favaretto
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D010347:Patient Care Planning; D011183:Postoperative Complications; D012307:Risk Factors